Hyperfine (HYPR) Total Non-Current Liabilities (2022 - 2026)
Hyperfine's (HYPR) quarterly Total Non-Current Liabilities came in at $26.0 million in Q1 2026, up 152.96% YoY from $10.3 million in Q1 2025, and up 82.94% on a QoQ basis from $14.2 million in Q4 2025.
Hyperfine (HYPR) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Hyperfine (HYPR) has 5 years of Total Non-Current Liabilities data on file, last reported at $26.0 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 152.96% year-over-year to $26.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.0 million (up 152.96% YoY) and the FY2025 annual result came in at $14.2 million, up 45.06% from the prior year.
- Total Non-Current Liabilities improved to $26.0 million in Q1 2026, from $14.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $26.0 million in Q1 2026 to a low of $9.3 million in Q3 2023.
- A 5-year average of $11.9 million and a median of $10.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities slumped 30.35% — and 2026, when it soared 152.96%.
- Tracing HYPR's Total Non-Current Liabilities over 5 years: stood at $13.3 million in 2022, then decreased by 27.06% to $9.7 million in 2023, then rose by 0.48% to $9.8 million in 2024, then soared by 45.06% to $14.2 million in 2025, then jumped by 82.94% to $26.0 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $26.0 million (Q1 2026), $14.2 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.92 Bn | 196.32 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.03 Bn | 109.81 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.38 Bn | 73.84 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.74 Bn | 47.49 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.06 Bn | 33.11 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.81 Bn | 31.70 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.25 Bn | 22.93 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Hyperfine | 90.20 Mn | 45.43 Mn | 1.98 Mn | 26.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.24 Mn |
| Mar 31, 2026 | 25.96 Mn |
| Dec 31, 2025 | 14.19 Mn |
| Sep 30, 2025 | 14.64 Mn |
| Jun 30, 2025 | 10.10 Mn |
| Mar 31, 2025 | 10.26 Mn |
| Dec 31, 2024 | 9.78 Mn |
| Sep 30, 2024 | 11.06 Mn |
| Jun 30, 2024 | 9.85 Mn |
| Mar 31, 2024 | 9.81 Mn |
| Dec 31, 2023 | 9.74 Mn |
| Sep 30, 2023 | 9.30 Mn |
| Jun 30, 2023 | 9.32 Mn |
| Mar 31, 2023 | 9.37 Mn |
| Sep 30, 2022 | 13.35 Mn |
| Jun 30, 2022 | 11.20 Mn |